BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moore JK, Stutchfield BM, Forbes SJ. Systematic review: the effects of autologous stem cell therapy for patients with liver disease. Aliment Pharmacol Ther. 2014;39:673-685. [PMID: 24528093 DOI: 10.1111/apt.12645] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Choi JS, Jeong IS, Han JH, Cheon SH, Kim S. IL-10-secreting human MSCs generated by TALEN gene editing ameliorate liver fibrosis through enhanced anti-fibrotic activity. Biomater Sci 2019;7:1078-87. [DOI: 10.1039/c8bm01347k] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
2 Khan S, Khan RS, Newsome PN. Cell Therapy for Liver Disease: From Promise to Reality. Semin Liver Dis 2020;40:411-26. [PMID: 33764490 DOI: 10.1055/s-0040-1717096] [Reference Citation Analysis]
3 King A, Houlihan DD, Kavanagh D, Haldar D, Luu N, Owen A, Suresh S, Than NN, Reynolds G, Penny J, Sumption H, Ramachandran P, Henderson NC, Kalia N, Frampton J, Adams DH, Newsome PN. Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis. Gastroenterology 2017;153:233-248.e16. [PMID: 28363640 DOI: 10.1053/j.gastro.2017.03.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
4 Ciccocioppo R, Dos Santos CC, Baumgart DC, Cangemi GC, Cardinale V, Ciacci C, De Coppi P, Haldar D, Klersy C, Nostro MC, Ott M, Piemonti L, Tomei AA, Uygun B, Vetrano S, Orlando G. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. Cytotherapy 2018;20:461-76. [PMID: 29398624 DOI: 10.1016/j.jcyt.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Singhal M, Liu X, Inverso D, Jiang K, Dai J, He H, Bartels S, Li W, Abdul Pari AA, Gengenbacher N, Besemfelder E, Hui L, Augustin HG, Hu J. Endothelial cell fitness dictates the source of regenerating liver vasculature. J Exp Med 2018;215:2497-508. [PMID: 30194265 DOI: 10.1084/jem.20180008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
6 Rockey DC, Friedman SL. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside. Gastroenterology 2021;160:1502-1520.e1. [PMID: 33529675 DOI: 10.1053/j.gastro.2020.09.065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 Verma N, Singh A, Singh V. Haematopoietic stem cells in cirrhosis. Lancet Gastroenterol Hepatol 2018;3:298. [PMID: 29644972 DOI: 10.1016/S2468-1253(18)30041-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Jindal A, Jagdish RK, Kumar A. Hepatic Regeneration in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.029] [Reference Citation Analysis]
9 Dwyer BJ, Macmillan MT, Brennan PN, Forbes SJ. Cell therapy for advanced liver diseases: Repair or rebuild. J Hepatol 2021;74:185-99. [PMID: 32976865 DOI: 10.1016/j.jhep.2020.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Mahmood A, Seetharaman R, Kshatriya P, Patel D, Srivastava AS. Stem Cell Transplant for Advanced Stage Liver Disorders: Current Scenario and Future Prospects. Curr Med Chem 2020;27:6276-93. [PMID: 31584360 DOI: 10.2174/0929867326666191004161802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Su DN, Wu SP, Xu SZ. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis. Stem Cell Res Ther 2020;11:395. [PMID: 32928296 DOI: 10.1186/s13287-020-01911-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Rajaram R, Subramani B, Abdullah BJJ, Mahadeva S. Mesenchymal stem cell therapy for advanced liver cirrhosis: A case report. JGH Open 2017;1:153-5. [PMID: 30483553 DOI: 10.1002/jgh3.12027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Than NN, Tomlinson CL, Haldar D, King AL, Moore D, Newsome PN. Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol. Syst Rev. 2016;5:100. [PMID: 27301957 DOI: 10.1186/s13643-016-0277-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
14 Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut 2015;64:830-41. [PMID: 25681399 DOI: 10.1136/gutjnl-2014-306842] [Cited by in Crossref: 550] [Cited by in F6Publishing: 497] [Article Influence: 78.6] [Reference Citation Analysis]
15 Kholodenko IV, Yarygin KN. Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases. Biomed Res Int. 2017;2017:8910821. [PMID: 28210629 DOI: 10.1155/2017/8910821] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
16 Alizadeh E, Eslaminejad MB, Akbarzadeh A, Sadeghi Z, Abasi M, Herizchi R, Zarghami N. Upregulation of MiR-122 via Trichostatin A Treatments in Hepatocyte-like Cells Derived from Mesenchymal Stem Cells. Chem Biol Drug Des 2016;87:296-305. [PMID: 26360933 DOI: 10.1111/cbdd.12664] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
17 Campana L, Esser H, Huch M, Forbes S. Liver regeneration and inflammation: from fundamental science to clinical applications. Nat Rev Mol Cell Biol 2021;22:608-24. [PMID: 34079104 DOI: 10.1038/s41580-021-00373-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Andreone P, Catani L, Margini C, Brodosi L, Lorenzini S, Sollazzo D, Nicolini B, Giordano R, Montemurro T, Rizzi S, Dan E, Giudice V, Viganò M, Casadei A, Foschi FG, Malvi D, Bernardi M, Conti F, Lemoli RM. Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial. Dig Liver Dis 2015;47:1059-66. [PMID: 26427587 DOI: 10.1016/j.dld.2015.08.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lanthier N, Stärkel P. Treatment of severe alcoholic hepatitis: past, present and future. Eur J Clin Invest 2017;47:531-9. [PMID: 28517024 DOI: 10.1111/eci.12767] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
20 Nishina T, Hoshikawa KT, Ueno Y. Current Cell-Based Therapies in the Chronic Liver Diseases. Adv Exp Med Biol 2018;1103:243-53. [PMID: 30484233 DOI: 10.1007/978-4-431-56847-6_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Choi JS, Park YJ, Kim SW. Three-dimensional Differentiated Human Mesenchymal Stem Cells Exhibit Robust Antifibrotic Potential and Ameliorates Mouse Liver Fibrosis. Cell Transplant 2021;30:963689720987525. [PMID: 33555212 DOI: 10.1177/0963689720987525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Lanthier N, Lin-Marq N, Rubbia-Brandt L, Clément S, Goossens N, Spahr L. Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns? Stem Cell Res Ther 2017;8:88. [PMID: 28420441 DOI: 10.1186/s13287-017-0541-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
23 Rathi S, Hussaini T, Yoshida EM. Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis. Ann Hepatol 2021;20:100211. [PMID: 32533952 DOI: 10.1016/j.aohep.2020.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Forbes SJ. Milk Fat Globule-EGF Factor 8 for Liver Fibrosis Therapy: Creaming Off the Beneficial Effects of Mesenchymal Stromal Cells. Gastroenterology 2017;152:943-6. [PMID: 28259796 DOI: 10.1053/j.gastro.2017.02.032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Matsumoto T, Takami T, Sakaida I. Cell transplantation as a non-invasive strategy for treating liver fibrosis. Expert Rev Gastroenterol Hepatol 2016;10:639-48. [PMID: 26691057 DOI: 10.1586/17474124.2016.1134313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
26 Carpino G, Renzi A, Franchitto A, Cardinale V, Onori P, Reid L, Alvaro D, Gaudio E. Stem/Progenitor Cell Niches Involved in Hepatic and Biliary Regeneration. Stem Cells Int 2016;2016:3658013. [PMID: 26880956 DOI: 10.1155/2016/3658013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
27 Müller P, Voronina N, Hausburg F, Lux CA, Wiekhorst F, Steinhoff G, David R. Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells. Stem Cells Int 2016;2016:7152761. [PMID: 27795713 DOI: 10.1155/2016/7152761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
28 Moore JK, Mackinnon AC, Wojtacha D, Pope C, Fraser AR, Burgoyne P, Bailey L, Pass C, Atkinson A, Mcgowan NW. Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study. Cytotherapy. 2015;17:1604-1616. [PMID: 26342993 DOI: 10.1016/j.jcyt.2015.07.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
29 Forbes SJ, Newsome PN. Liver regeneration - mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol. 2016;13:473-485. [PMID: 27353402 DOI: 10.1038/nrgastro.2016.97] [Cited by in Crossref: 152] [Cited by in F6Publishing: 138] [Article Influence: 25.3] [Reference Citation Analysis]
30 Ma HC, Shi XL, Ren HZ, Yuan XW, Ding YT. Genetically modified mesenchymal stem cells overexpressing CXCR4 show increased colonization ability and confer better liver regeneration in mice. Shijie Huaren Xiaohua Zazhi 2014; 22(16): 2229-2236 [DOI: 10.11569/wcjd.v22.i16.2229] [Reference Citation Analysis]
31 King A, Barton D, Beard HA, Than N, Moore J, Corbett C, Thomas J, Guo K, Guha I, Hollyman D, Stocken D, Yap C, Fox R, Forbes SJ, Newsome PN. REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. BMJ Open 2015;5:e007700. [PMID: 25795699 DOI: 10.1136/bmjopen-2015-007700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
32 Boyd A, Newsome P, Lu W. The role of stem cells in liver injury and repair. Expert Review of Gastroenterology & Hepatology 2019;13:623-31. [DOI: 10.1080/17474124.2019.1618186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
33 Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: From liver transplantation to cell factory. J Hepatol. 2015;62:S157-S169. [PMID: 25920085 DOI: 10.1016/j.jhep.2015.02.040] [Cited by in Crossref: 160] [Cited by in F6Publishing: 154] [Article Influence: 26.7] [Reference Citation Analysis]
34 Ma HC, Wang X, Wu MN, Zhao X, Yuan XW, Shi XL. Interleukin-10 Contributes to Therapeutic Effect of Mesenchymal Stem Cells for Acute Liver Failure via Signal Transducer and Activator of Transcription 3 Signaling Pathway. Chin Med J (Engl) 2016;129:967-75. [PMID: 27064043 DOI: 10.4103/0366-6999.179794] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
35 Shiota G, Itaba N. Progress in stem cell-based therapy for liver disease. Hepatol Res. 2017;47:127-141. [PMID: 27188253 DOI: 10.1111/hepr.12747] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
36 Lin YC, Harn HJ, Lin PC, Chuang MH, Chen CH, Lin SZ, Chiou TW. Commercial Production of Autologous Stem Cells and Their Therapeutic Potential for Liver Cirrhosis. Cell Transplant 2017;26:449-60. [PMID: 27718343 DOI: 10.3727/096368916X693310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
37 Prajapati R, Arora A, Sharma P, Bansal N, Singla V, Kumar A. Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial. Eur J Gastroenterol Hepatol 2017;29:448-55. [PMID: 27930386 DOI: 10.1097/MEG.0000000000000801] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
38 Giancotti A, D'ambrosio V, Corno S, Pajno C, Carpino G, Amato G, Vena F, Mondo A, Spiniello L, Monti M, Muzii L, Bosco D, Gaudio E, Alvaro D, Cardinale V. Current protocols and clinical efficacy of human fetal liver cell therapy in patients with liver disease: A literature review. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.10.012] [Reference Citation Analysis]
39 Lanthier N. Haemopoietic stem cell therapy in cirrhosis: the end of the story? Lancet Gastroenterol Hepatol 2018;3:3-5. [PMID: 29127062 DOI: 10.1016/S2468-1253(17)30359-X] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
40 Giancotti A, Monti M, Nevi L, Safarikia S, D’Ambrosio V, Brunelli R, Pajno C, Corno S, Di Donato V, Musella A, Chiappetta MF, Bosco D, Panici PB, Alvaro D, Cardinale V. Functions and the Emerging Role of the Foetal Liver into Regenerative Medicine. Cells 2019;8:E914. [PMID: 31426422 DOI: 10.3390/cells8080914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
41 Newsome PN, Fox R, King AL, Barton D, Than NN, Moore J, Corbett C, Townsend S, Thomas J, Guo K, Hull D, Beard HA, Thompson J, Atkinson A, Bienek C, McGowan N, Guha N, Campbell J, Hollyman D, Stocken D, Yap C, Forbes SJ. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3:25-36. [PMID: 29127060 DOI: 10.1016/s2468-1253(17)30326-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 30] [Article Influence: 12.6] [Reference Citation Analysis]
42 Ma HC, Shi XL, Ding YT. Synergistic effect of IL-1β siRNA combined with mesenchymal stem cells in treatment of acute liver failure in mice. Shijie Huaren Xiaohua Zazhi 2014; 22(30): 4547-4558 [DOI: 10.11569/wcjd.v22.i30.4547] [Reference Citation Analysis]
43 Zhai R, Wang Y, Qi L, Williams GM, Gao B, Song G, Burdick JF, Sun Z. Pharmacological Mobilization of Endogenous Bone Marrow Stem Cells Promotes Liver Regeneration after Extensive Liver Resection in Rats. Sci Rep 2018;8:3587. [PMID: 29483616 DOI: 10.1038/s41598-018-21961-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
44 Kim D, Cho GS, Han C, Park DH, Park HK, Woo DH, Kim JH. Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases. Tissue Eng Regen Med 2017;14:653-65. [PMID: 30603518 DOI: 10.1007/s13770-017-0093-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]